Savara Statistics
NASDAQ: SVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.83-0.05 (-1.02%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Savara by the numbers
Savara has a market capitalization of $992.4 million based on 205.46M shares outstanding. With trailing EPS of $-0.58, Savara is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.4% below its 50-day average and 12.1% below its 200-day average.
Average daily trading volume is 1.83M shares, or about $8.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SVRA valuation vs. peer median
| Metric | SVRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $992.37M | $969.65M | +2% |
| Avg. volume | 1.83M | 431.76K | +324% |
Peer median across 8 companies: AKTS, OPK, LTGO, SPTX, ANRO, KURA, RIGL, AMPH.
Valuation
- Market cap
- $992.37M
- EPS (TTM)
- $-0.58
- Shares outstanding
- 205.46M
Price and trading
- Previous close
- 4.88
- Open
- 4.85
- Day range
- 4.64 – 4.92
- 52-week range
- 3.35 – 7.01
- 52-week change
- +42.27%
- Beta
- —
- Volume
- 2.51M
- Average volume
- 1.83M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 992.37M
- Forward Pe
- -13.16
- Eps
- -0.58
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.01
- Week52 Low
- 3.35
- Avg Volume
- 1.83M
- Shares Outstanding
- 205.46M
- Ma50
- 5.33
- Ma200
- 5.50
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -31.05%
- Pct From52w Low
- 44.18%